Research & Development

Can Extended Apixaban Therapy Prevent Recurrent VTE Safely?
Research & Development Can Extended Apixaban Therapy Prevent Recurrent VTE Safely?

Imagine a patient recovering from a provoked venous thromboembolism (VTE), such as deep vein thrombosis (DVT) triggered by surgery, only to face an ongoing risk of recurrence due to chronic conditions like obesity or inflammatory disorders. With recurrence rates posing a significant threat to

How Do Genomic Clues Reveal Early Multiple Myeloma Origins?
Research & Development How Do Genomic Clues Reveal Early Multiple Myeloma Origins?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a deep understanding of technology and innovation in the industry, has positioned him as a leading voice in cancer research. Today, we’ll dive into his

Can AI Revolutionize Drug Discovery with Natural Compounds?
Research & Development Can AI Revolutionize Drug Discovery with Natural Compounds?

In the fast-paced realm of healthcare innovation, a remarkable partnership between Singapore-based Nanyang Biologics (NYB), global digital infrastructure giant Equinix, and technology leader Hewlett Packard Enterprise (HPE) is capturing attention across the industry. This collaboration has given

How Did QEH Become UK's Fastest in Hip Fracture Research?
Research & Development How Did QEH Become UK's Fastest in Hip Fracture Research?

In a landscape where medical research often progresses at a cautious pace, the Queen Elizabeth Hospital (QEH) has emerged as a trailblazer, setting a remarkable benchmark in the United Kingdom by achieving the extraordinary feat of becoming the fastest site in the UK to recruit 100 participants for

Can Tumor Microbiota Predict Gastrointestinal Cancer Outcomes?
Research & Development Can Tumor Microbiota Predict Gastrointestinal Cancer Outcomes?

Imagine a future where a simple microbial profile from a tumor biopsy could predict a patient’s likelihood of surviving gastrointestinal (GI) cancer or responding to cutting-edge therapies. This isn’t science fiction—it’s a tangible possibility emerging from the intersection of microbiology and

Can Rare HIV Cures Lead to a Universal Immunotherapy?
Research & Development Can Rare HIV Cures Lead to a Universal Immunotherapy?

What if a tiny fraction of people held the key to eradicating one of humanity's most persistent viruses, offering hope to the over 38 million individuals living with HIV worldwide? This virus has defied a universal cure for decades, yet in a handful of remarkable cases, some have walked away

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later